The Valley Desk

NCT03685331 · Interventional trial

HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

Overall registry status Completed

Phase 1

Conditions Advanced Breast Cancer, BRCA1 Mutation, BRCA2 Mutation, Locally Advanced Breast Cancer, Metastatic Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov